Eagle Global Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History

Eagle Global Advisors’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-52,767	Closed	-$369K	–	278
2017 Q2	$369K	Hold	52,767	–	–	0.01%	266
2017 Q1	$366K	Hold	52,767	–	–	0.01%	253
2016 Q4	$290K	Hold	52,767	–	–	0.01%	276
2016 Q3	$264K	Sell	52,767 -30,768	-37%	-$145K	0.01%	282
2016 Q2	$376K	Buy	83,535 +6,639	+9%	+$30.4K	0.01%	232
2016 Q1	$345K	Hold	76,896	–	–	0.01%	250
2015 Q4	$404K	Hold	76,896	–	–	0.01%	233
2015 Q3	$444K	Buy	76,896 +15,740	+26%	+$98.1K	0.01%	220
2015 Q2	$437K	Buy	61,156 +36,186	+145%	+$252K	0.01%	236
2015 Q1	$166K	Buy	+24,970	New	+$156K	﹤0.01%	326

Other funds holding CPIX

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

JAM

JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Eagle Global Advisors's CPIX Position: Q3 2017 in Review

Eagle Global Advisors sold out of Cumberland Pharmaceuticals (CPIX) in Q3 2017, closing a stake of 52,767 shares — an estimated $369K sold.

Eagle Global Advisors first reported a position in CPIX in Q1 2015 and held it in 10 quarters. The position peaked at $444K in Q3 2015. 33 funds tracked by Wall St. Rank hold CPIX as of Q3 2017.

Eagle Global Advisors reported no remaining Cumberland Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
Eagle Global Advisors sold 52,767 Cumberland Pharmaceuticals shares in Q3 2017, an estimated $369K.
Eagle Global Advisors first reported a position in Cumberland Pharmaceuticals in Q1 2015 and held it in 10 quarters.
Eagle Global Advisors's Cumberland Pharmaceuticals position peaked at $444K in Q3 2015.
33 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2017.

Based on Eagle Global Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.